Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.
Escherichia coli G3/10 is a component of the probiotic drug Symbioflor 2. In an in vitro assay with human intestinal epithelial cells, E. coli G3/10 is capable of suppressing adherence of enteropathogenic E. coli E2348/69. In this study, we demonstrate that a completely novel class II microcin, prod...
Guardado en:
Autores principales: | Anke Zschüttig, Kurt Zimmermann, Jochen Blom, Alexander Goesmann, Christoph Pöhlmann, Florian Gunzer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0e276b5af514a888fc888072d06af76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
por: Sya N Ukena, et al.
Publicado: (2007) -
Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Teresa Pérez-Berezo, et al.
Publicado: (2017) -
In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy
por: Chung-Jen Chiang, et al.
Publicado: (2021) -
Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors
por: Chung-Jen Chiang, et al.
Publicado: (2021) -
Impact of Escherichia coli probiotic strains ED1a and Nissle 1917 on the excretion and gut carriage of extended-spectrum beta-lactamase-producing E. coli in pigs
por: Gwénaëlle Mourand, et al.
Publicado: (2021)